Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) sequentially upregulates nitric oxide and prostanoid production in primary human endothelial cells. [electronic resource]
Producer: 20030425Description: 732-40 p. digitalISSN:- 1524-4571
- Actins -- drug effects
- Apoptosis Regulatory Proteins
- Calcium -- metabolism
- Cell Movement -- drug effects
- Cells, Cultured
- Chromones -- pharmacology
- Cyclooxygenase Inhibitors -- pharmacology
- Endothelium, Vascular -- cytology
- Enzyme Activation -- drug effects
- Enzyme Inhibitors -- pharmacology
- Humans
- Membrane Glycoproteins -- pharmacology
- Morpholines -- pharmacology
- NG-Nitroarginine Methyl Ester -- pharmacology
- Nitric Oxide -- metabolism
- Nitric Oxide Synthase -- antagonists & inhibitors
- Nitric Oxide Synthase Type III
- Nitrobenzenes -- pharmacology
- Phosphoinositide-3 Kinase Inhibitors
- Phosphorylation -- drug effects
- Prostaglandins -- metabolism
- Pyrazoles -- pharmacology
- Serine -- metabolism
- Sulfonamides -- pharmacology
- TNF-Related Apoptosis-Inducing Ligand
- Time Factors
- Tumor Necrosis Factor-alpha -- pharmacology
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.